Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Lung Cancer

  Free Subscription

Articles published in Carcinogenesis

Retrieve available abstracts of 39 articles:
HTML format

Single Articles

    August 2023
  1. BLECHTER B, Wong JYY, Hu W, Cawthon R, et al
    Exposure to smoky coal combustion emissions and leukocyte Alu retroelement copy number.
    Carcinogenesis. 2023;44:404-410.
    PubMed     Abstract available

    June 2023
  2. BAGHERPOOR AJ, Shameem M, Luo X, Seelig D, et al
    Inhibition of lung adenocarcinoma by combinations of sulfasalazine (SAS) and disulfiram-copper (DSF-Cu) in cell line models and mice.
    Carcinogenesis. 2023;44:291-303.
    PubMed     Abstract available

    May 2023
  3. PU J, Teng Z, Yang W, Zhu P, et al
    Construction of a prognostic model for lung squamous cell carcinoma based on immune-related genes.
    Carcinogenesis. 2023;44:143-152.
    PubMed     Abstract available

  4. CHEN J, Li J, Sun H, Hu T, et al
    PPM1G promotes the progression of lung adenocarcinoma by inhibiting p38 activation via dephosphorylation of MEK6.
    Carcinogenesis. 2023;44:93-104.
    PubMed     Abstract available

  5. OTA K, Sakai S, Ohhata T, Suzuki T, et al
    APOBEC3B expression is promoted by lincNMR collaborating with TGF-beta-Smad pathway.
    Carcinogenesis. 2023;44:1-14.
    PubMed     Abstract available

  6. TANG Q, Zhou Q, Li J, Yang X, et al
    Solamargine enhanced gefitinib anti-tumor effect via regulating MALAT1/miR-141-3p/Sp1/IGFBP1 signaling pathway in non-small cell lung cancer.
    Carcinogenesis. 2023 May 5:bgad028. doi: 10.1093.
    PubMed     Abstract available

    April 2023
  7. ZHANG Y, Liu X, Dang W, Liu L, et al
    Thymoquinone inhibits lung cancer stem cell properties via triggering YAP degradation.
    Carcinogenesis. 2023 Apr 27:bgad026. doi: 10.1093.
    PubMed     Abstract available

    December 2022
  8. LI S, Chen Z, Zhang W, Wang T, et al
    Elevated expression of the membrane-anchored serine protease TMPRSS11E in NSCLC progression.
    Carcinogenesis. 2022;43:1092-1102.
    PubMed     Abstract available

    October 2022
  9. ZHAO L, Lei J, Gu S, Zhang Y, et al
    A yes-associated protein 1-Notch1 positive feedback loop promotes breast cancer lung metastasis by attenuating the Bone morphogenetic protein 4-SMAD family member 1/5 signaling.
    Carcinogenesis. 2022 Oct 4. pii: 6748174. doi: 10.1093.
    PubMed     Abstract available

    August 2022
  10. LU F, Zhou J, Chen Q, Zhu J, et al
    PSMA5 contributes to progression of lung adenocarcinoma in association with the JAK/STAT pathway.
    Carcinogenesis. 2022;43:624-634.
    PubMed     Abstract available

  11. SATOH H, Arai Y, Furukawa E, Moriguchi T, et al
    Genomic landscape of chemical-induced lung tumors under Nrf2 different expression levels.
    Carcinogenesis. 2022;43:613-623.
    PubMed     Abstract available

  12. BIAN T, Ding H, Wang Y, Hu Q, et al
    Suppressing the activation of protein kinase A as a DNA damage-independent mechanistic lead for dihydromethysticin prophylaxis of NNK-induced lung carcinogenesis.
    Carcinogenesis. 2022;43:659-670.
    PubMed     Abstract available

    June 2022
  13. KASSIE F, Bagherpoor AJ, Kovacs K, Seelig D, et al
    Combinatory lung tumor inhibition by myo-inositol and iloprost/rapamycin: association with immunomodulation.
    Carcinogenesis. 2022;43:547-556.
    PubMed     Abstract available

  14. FENG J, Ouyang H, Wang J, Pan D, et al
    MPZL1 upregulation promotes tumor metastasis and correlates with unfavorable prognosis in non-small cell lung cancer.
    Carcinogenesis. 2022 Jun 21. pii: 6612224. doi: 10.1093.
    PubMed     Abstract available

  15. ZHAO A, Li F, Wei C, Zhou Z, et al
    TNFalpha antagonist in combination with PD-1 blocker to prevent or retard malignant transformation of B[a]P-induced chronic lung inflammation.
    Carcinogenesis. 2022;43:445-456.
    PubMed     Abstract available

    May 2022
  16. YOON HS, Shu XO, Cai H, Zheng W, et al
    Associations of Lung Cancer Risk with Biomarkers of Helicobacter pylori Infection.
    Carcinogenesis. 2022 May 24. pii: 6590911. doi: 10.1093.
    PubMed     Abstract available

    March 2022
  17. HU Q, Upadhyaya P, Hecht SS, Aly FZ, et al
    Characterization of adductomic totality of NNK, (R)-NNAL and (S)-NNAL in A/J mice, and their correlations with distinct lung carcinogenicity.
    Carcinogenesis. 2022;43:170-181.
    PubMed     Abstract available

    February 2022
  18. MENG Z, Zhang R, Wu X, Zhang M, et al
    Prognostic value of Mortalin correlates with roles in epithelial-mesenchymal transition and angiogenesis in lung adenocarcinoma.
    Carcinogenesis. 2022;43:40-51.
    PubMed     Abstract available

    January 2022
  19. ZHANG Q, Jia Y, Pan P, Zhang X, et al
    alpha5-nAChR associated with Ly6E modulates cell migration via TGF-beta1/Smad signaling in non-small cell lung cancer.
    Carcinogenesis. 2022 Jan 5. pii: 6498141. doi: 10.1093.
    PubMed     Abstract available

    December 2021
  20. DONNELLY LL, Hogan TC, Lenahan SM, Nandagopal G, et al
    Functional assessment of somatic STK11 variants identified in primary human non-small cell lung cancers.
    Carcinogenesis. 2021;42:1428-1438.
    PubMed     Abstract available

  21. XU R, Yan Y, Zheng X, Zhang H, et al
    Aspirin Suppresses Breast Cancer Metastasis to Lung by Targeting Anoikis Resistance.
    Carcinogenesis. 2021 Dec 27. pii: 6484923. doi: 10.1093.
    PubMed     Abstract available

  22. YANG L, Wu D, Chen J, Chen J, et al
    Corrigendum to: A functional CNVR_3425.1 damping lincRNA FENDRR increases lifetime risk of lung cancer and COPD in Chinese.
    Carcinogenesis. 2021 Dec 23. pii: 6481929. doi: 10.1093.

  23. LI H, Zhao S, Chen X, Feng G, et al
    MiR-145 modulates the radiosensitivity of non-small cell lung cancer cells by suppression of TMOD3.
    Carcinogenesis. 2021 Dec 9. pii: 6458453. doi: 10.1093.
    PubMed     Abstract available

  24. HUDLIKAR RR, Sargsyan D, Cheng D, Kuo HD, et al
    Tobacco carcinogen 4-[Methyl(nitroso)amino]-1-(3-pyridinyl)-1-butanone (NNK) drives metabolic rewiring and epigenetic reprograming in A/J mice lung cancer model and prevention with Diallyl Sulphide (DAS).
    Carcinogenesis. 2021 Dec 9. pii: 6458449. doi: 10.1093.
    PubMed     Abstract available

    October 2021
  25. WANG M, Li S, Guo W, Wang L, et al
    CHRAC1 promotes human lung cancer growth through regulating YAP transcriptional activity.
    Carcinogenesis. 2021 Oct 27. pii: 6412599. doi: 10.1093.
    PubMed     Abstract available

    September 2021
  26. ANG L, Ghosh P, Seow WJ
    Association between previous lung diseases and lung cancer risk: a systematic review and meta-analysis.
    Carcinogenesis. 2021 Sep 6. pii: 6364950. doi: 10.1093.
    PubMed     Abstract available

    August 2021
  27. HE T, Ling F
    CALCR knockdown inhibits the development and progression of non-small-cell lung cancer.
    Carcinogenesis. 2021 Aug 21. pii: 6356050. doi: 10.1093.
    PubMed     Abstract available

  28. TAO K, Liu J, Liang J, Xu X, et al
    Vascular endothelial cell-derived exosomal miR-30a-5p inhibits lung adenocarcinoma malignant progression by targeting CCNE2.
    Carcinogenesis. 2021;42:1056-1067.
    PubMed     Abstract available

  29. WANG Q, Ru M, Zhang Y, Kurbanova T, et al
    Dietary phytoestrogen intake and lung cancer risk: an analysis of the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial.
    Carcinogenesis. 2021 Aug 9. pii: 6346800. doi: 10.1093.
    PubMed     Abstract available

    July 2021
  30. WANG Y, Ji M, Zhu M, Fan J, et al
    Genome-wide gene-smoking interaction study identified novel susceptibility loci for non-small cell lung cancer in Chinese populations.
    Carcinogenesis. 2021 Jul 23. pii: 6326566. doi: 10.1093.
    PubMed     Abstract available

  31. CHEN W, Saxton B, Tessema M, Belinsky SA, et al
    Inhibition of GFAT1 in lung cancer cells destabilizes PD-L1 protein.
    Carcinogenesis. 2021 Jul 16. pii: 6322888. doi: 10.1093.
    PubMed     Abstract available

  32. LI Z, Pan C, Wang Z, Deng X, et al
    LncRNA PCBP1-AS1 correlated with the functional states of cancer cells and inhibited lung adenocarcinoma metastasis by suppressing the EMT progression.
    Carcinogenesis. 2021;42:931-939.
    PubMed     Abstract available

  33. CUI D, Zhu Y, Yan D, Lee NPY, et al
    Dual inhibition of cMET and EGFR by microRNA-338-5p suppresses metastasis of esophageal squamous cell carcinoma.
    Carcinogenesis. 2021;42:995-1007.
    PubMed     Abstract available

    June 2021
  34. XIAN J, Zeng Y, Chen S, Lu L, et al
    Discovery of a novel linc01125 isoform in serum exosomes as a promising biomarker for NSCLC diagnosis and survival assessment.
    Carcinogenesis. 2021;42:831-841.
    PubMed     Abstract available

  35. CHEN H, Lu C, Lin C, Li L, et al
    VPS34 suppression reverses osimertinib resistance via simultaneously inhibiting glycolysis and autophagy.
    Carcinogenesis. 2021;42:880-890.
    PubMed     Abstract available

    April 2021
  36. JIANG T, Wu H, Lin M, Yin J, et al
    B4GALNT1 promotes progression and metastasis in lung adenocarcinoma through JNK/c-Jun/Slug pathway.
    Carcinogenesis. 2021;42:621-630.
    PubMed     Abstract available

  37. GUI HX, Peng J, Yang ZP, Chen LY, et al
    HDAC1-Smad3-mSin3A complex is required for Smad3-induced transcriptional inhibition of hepatocyte growth factor receptor in human lung cancers.
    Carcinogenesis. 2021;42:587-600.
    PubMed     Abstract available

    February 2021
  38. HAMADA K, Tian Y, Fujimoto M, Takahashi Y, et al
    DNA hypermethylation of the ZNF132 gene participates in the clinicopathological aggressiveness of 'pan-negative'-type lung adenocarcinomas.
    Carcinogenesis. 2021;42:169-179.
    PubMed     Abstract available

  39. LI P, Zhang X, Murphy AJ, Costa M, et al
    Downregulation of hedgehog-interacting protein (HHIP) contributes to hexavalent chromium-induced malignant transformation of human bronchial epithelial cells.
    Carcinogenesis. 2021;42:136-147.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.